封面
市場調查報告書
商品編碼
1458006

全球胃腸出血治療市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Gastrointestinal Bleeding Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 222 Pages | 商品交期: 最快1-2個工作天內

價格

預計到 2032 年,全球胃腸出血治療市場的市場規模將從 2023 年的 551.49 萬美元達到近 942.87 萬美元,2024-2032 年研究期間CAGR為 6.14%。

胃腸道出血治療涉及解決消化道出血問題,消化道出血可能由多種疾病引起,例如潰瘍、憩室病或胃腸道腫瘤。治療方法可能包括內視鏡介入、藥物治療,或在嚴重的情況下,透過外科手術來控制出血並解決根本原因。及時診斷和治療對於預防併發症和確保患者健康至關重要。這種疾病的治療是根據出血的部位和嚴重程度來製定的,以止血並促進癒合。

市場動態

在醫療保健領域的多種因素的推動下,胃腸道出血治療市場正在經歷顯著成長。胃腸道出血性疾病的發生率不斷上升,通常與消化性潰瘍和發炎性腸道疾病等疾病有關,這推動了對有效治療方案的需求。醫療技術的進步,包括內視鏡手術和介入放射學,有助於改善診斷和微創治療方法。全球人口老化,容易出現胃腸道問題,進一步促進了市場的成長。此外,慢性病盛行率的不斷上升和抗凝血藥物的使用增加了胃腸道出血的風險,因此需要及時有效的治療方案。對早期檢測和介入的重視以及新療法的開發增強了胃腸道出血治療市場的活力。總而言之,胃腸道疾病盛行率不斷上升、醫療干預技術進步以及人口老化對有效和及時治療的需求推動了胃腸道出血治療市場的發展。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球胃腸道出血治療市場的各個細分市場進行了包容性評估。胃腸道出血治療產業的成長和趨勢為本研究提供了整體方法。

市場區隔

胃腸道出血治療市場報告的這一部分提供了國家和地區層面細分市場的詳細資料,從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

  • 內視鏡止血裝置(熱裝置、機械裝置)
  • 封閉裝置
  • 其他

胃腸道部門

  • 上消化道
  • 下胃腸道

按最終用戶

  • 醫院
  • 診所
  • 門診手術中心
  • 其他

區域分析

本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲胃腸出血治療市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

  • 全球胃腸出血治療市場佔有率(按地區)(代表性圖)
  • 全球胃腸道出血治療市場佔有率

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。胃腸出血治療市場的主要參與者包括波士頓科學公司、奧林巴斯公司、CONMED 公司、庫克集團、Ovesco Endoscopy AG、Erbe Elektromedizin GmbH、STERIS、US ​​Medical Innovations。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章:前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章:執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章:胃腸出血治療 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 胃腸道部門的市場吸引力分析
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析:按地區

第 4 章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章:全球胃腸出血治療市場分析:依產品

  • 按產品概述
  • 歷史和預測數據
  • 按產品分析
  • 內視鏡止血裝置(熱裝置、機械裝置)
  • 封閉裝置
  • 其他

第 6 章:全球胃腸出血治療市場分析:依胃腸道分類

  • 胃腸道部門概述
  • 歷史和預測數據
  • 胃腸道部門分析
  • 上消化道
  • 下胃腸道

第 7 章:全球胃腸出血治療市場分析:依最終使用者分類

  • 最終用戶概述
  • 歷史和預測數據
  • 最終用戶分析
  • 醫院
  • 診所
  • 門診手術中心
  • 其他

第 8 章:全球胃腸出血治療市場分析:依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 9 章:胃腸出血治療公司的競爭格局

  • 胃腸出血治療市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 10 章:公司簡介

  • 公司股份分析
  • 市場集中度
  • Boston Scientific Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Olympus Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • CONMED Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Cook Group
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Ovesco Endoscopy AG
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Erbe Elektromedizin GmbH
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • STERIS
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • US Medical Innovations
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中,財務詳細資訊和近期發展視情況而定,或者如果是私人公司,則可能不包括在內

Product Code: VMR112113917

The global demand for Gastrointestinal Bleeding Treatment Market is presumed to reach the market size of nearly USD 942.87 MN by 2032 from USD 551.49 MN in 2023 with a CAGR of 6.14% under the study period 2024 - 2032.

Gastrointestinal bleeding treatment involves addressing bleeding in the digestive tract, which can result from various conditions, such as ulcers, diverticulosis, or gastrointestinal tumors. Treatment approaches may include endoscopic interventions, medication, or, in severe cases, surgical procedures to control bleeding and address the underlying cause. Prompt diagnosis & treatment are crucial to prevent complications and ensure patient well-being. Treatment for this disorder is tailored based on the location and severity of the bleeding to stop hemorrhage and promote healing.

MARKET DYNAMICS

The gastrointestinal bleeding treatment market is witnessing significant growth driven by multiple factors within the healthcare landscape. The rising incidence of gastrointestinal bleeding disorders, often linked to conditions such as peptic ulcers and inflammatory bowel diseases, propels the demand for effective treatment options. Advances in medical technologies, including endoscopic procedures and interventional radiology, contribute to improved diagnosis and minimally invasive treatment approaches. The aging global population, susceptible to gastrointestinal issues, further amplifies the market's growth. Furthermore, the escalating prevalence of chronic diseases and the use of anticoagulant medications elevate the risk of gastrointestinal bleeding, necessitating prompt and efficient treatment solutions. The emphasis on early detection and intervention and the development of novel therapies enhance the gastrointestinal bleeding treatment market dynamics. In summary, the gastrointestinal bleeding treatment market is driven by the escalating prevalence of gastrointestinal disorders, technological advancements in medical interventions, and the aging demographics contributing to the demand for effective and timely treatments.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gastrointestinal bleeding treatment. The growth and trends of gastrointestinal bleeding treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the gastrointestinal bleeding treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Endoscopic Hemostatic Devices (Thermal Devices, Mechanical Devices)
  • Closure Devices
  • Others

By GI Tract Division

  • Upper GI Tract
  • Lower GI Tract

By End-User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Gastrointestinal Bleeding Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

  • GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
  • Global Gastrointestinal Bleeding Treatment Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Gastrointestinal Bleeding Treatment market include Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Group, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, STERIS, US Medical Innovations. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . GASTROINTESTINAL BLEEDING TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By GI Tract Division
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET ANALYSIS BY PRODUCT

  • 5.1 Overview by Product
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product
  • 5.4 Endoscopic Hemostatic Devices (Thermal Devices, Mechanical Devices) Historic and Forecast Sales by Regions
  • 5.5 Closure Devices Historic and Forecast Sales by Regions
  • 5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET ANALYSIS BY GI TRACT DIVISION

  • 6.1 Overview by GI Tract Division
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by GI Tract Division
  • 6.4 Upper GI Tract Historic and Forecast Sales by Regions
  • 6.5 Lower GI Tract Historic and Forecast Sales by Regions

7 . GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET ANALYSIS BY END-USER

  • 7.1 Overview by End-user
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-user
  • 7.4 Hospitals Historic and Forecast Sales by Regions
  • 7.5 Clinics Historic and Forecast Sales by Regions
  • 7.6 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
  • 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL GASTROINTESTINAL BLEEDING TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE GASTROINTESTINAL BLEEDING TREATMENT COMPANIES

  • 9.1. Gastrointestinal Bleeding Treatment Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF GASTROINTESTINAL BLEEDING TREATMENT INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Boston Scientific Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Olympus Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. CONMED Corporation
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Cook Group
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Ovesco Endoscopy AG
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Erbe Elektromedizin GmbH
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. STERIS
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. US Medical Innovations
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Endoscopic Hemostatic Devices (Thermal Devices, Mechanical Devices) Market Sales by Geography (USD MN)
  • Closure Devices Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by GI Tract Division (USD MN)
  • Upper GI Tract Market Sales by Geography (USD MN)
  • Lower GI Tract Market Sales by Geography (USD MN)
  • Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Gastrointestinal Bleeding Treatment Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Gastrointestinal Bleeding Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Gastrointestinal Bleeding Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by GI Tract Division
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Endoscopic Hemostatic Devices (Thermal Devices, Mechanical Devices) Market Sales by Geography (USD MN)
  • Closure Devices Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by GI Tract Division (USD MN)
  • Upper GI Tract Market Sales by Geography (USD MN)
  • Lower GI Tract Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Clinics Market Sales by Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.